Popliteal Nerve Block for Achilles Tendon Repair Surgery
Launched by UNIVERSITY OF TORONTO · Mar 14, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of a specific type of anesthesia called a popliteal nerve block during surgery for repairing an Achilles tendon that has ruptured. The goal is to understand how this nerve block affects pain after surgery, how quickly patients recover, and their overall quality of life. While this method is commonly used, there are risks involved, and the research aims to provide clearer information for patients and doctors about whether or not to use it during the surgery.
To participate in the trial, individuals need to be between the ages of 18 and 65 and scheduled for surgery to repair an acute Achilles tendon rupture. Certain health conditions, such as pre-existing nerve issues, pregnancy, or a history of significant psychiatric conditions, may prevent someone from joining the study. Participants will undergo the surgery with the potential to receive the nerve block and will be monitored for their pain levels and recovery over time. This study is not yet recruiting participants, but it aims to improve understanding and decision-making around pain management for this surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 - 65
- • ASA classification: I - III
- • BMI \< 35 kg/m2
- • Undergoing acute Achilles tendon repair surgery as a day surgery procedure
- Exclusion Criteria:
- • Pre-existing neurological deficits or peripheral neuropathy in the distribution of the tibial or common peroneal nerves
- • Local infection
- • Contraindication to regional anesthesia (e.g., bleeding diathesis, coagulopathy)
- • Chronic pain disorders
- • History of use of over 30 mg oxycodone or equivalent per day
- • Contraindication to any component of a standard multi-modal analgesia
- • Allergy to local anesthetics
- • History of significant psychiatric conditions that may affect patient assessment
- • Pregnancy
- • Inability to provide informed consent
- • Patient refusal of popliteal nerve blockade
- • Prior Achilles tendon surgeries on the operative leg
About University Of Toronto
The University of Toronto, a prestigious research institution, serves as a leading sponsor of clinical trials dedicated to advancing medical knowledge and improving patient care. With a commitment to innovation and excellence, the university fosters a collaborative environment that brings together multidisciplinary teams of experts in medicine, pharmacology, and public health. Through rigorous research methodologies and ethical standards, the University of Toronto aims to explore new therapies, assess treatment efficacy, and address critical health challenges, ultimately contributing to the global body of scientific knowledge and enhancing healthcare outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Trial Officials
Richard Brull, MD FRCPC
Principal Investigator
University Health Network, Toronto
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported